EUVIMEDEUVIMED entdecken
Open Access

Rare Variants in NEUROD1 and PDX1 Are Low-Penetrance Causes of MODY, Whereas Those in APPL1 and WFS1 Are Not Associated With MODY

Aparajita Sriram, Matthew N Wakeling, Andrew T Hattersley iD, Michael N Weedon iD, Kevin Colclough iD, Thomas W Laver iD, Kashyap A Patel iD

Diabetes · 2025

DOI: 10.2337/db25-0442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Aparajita Sriram und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biomedical Science, University of Exeter, Exeter, U.K. Hauptthemen laut MEDLINE: Trans-Activators, Diabetes Mellitus, Type 2, Membrane Proteins, Basic Helix-Loop-Helix Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, European Foundation for the Study of Diabetes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An accurate genetic diagnosis of maturity-onset diabetes of the young (MODY) is critical for personalized treatment. To avoid misdiagnosis, only genes with strong evidence of causality must be tested. Heterozygous variants in NEUROD1, PDX1, APPL1, and WFS1 have been implicated in MODY, but strong genetic evidence supporting causality is lacking. We therefore assessed their existing genetic evidence and performed gene-level burden tests in a large MODY cohort, alongside two established MODY genes as positive controls (HNF1A-high penetrance, RFX6-low penetrance). The first reported MODY-associated variants in NEUROD1, PDX1, APPL1, and WFS1 were <1:20,000 frequency. Based on the small number of large published pedigrees per gene (n < 3), MODY-associated variants showed only modest cosegregation in these genes. Crucially, ultra-rare (minor allele frequency <1:10,000) protein-truncating and predicted-damaging missense variants in APPL1 and WFS1 were not enriched in a MODY cohort (n = 2,571) compared with population control individuals (n = 155,501; all P > 0.05). In contrast, variants in NEUROD1 and PDX1 were enriched, albeit at levels comparable to RFX6. Multiple sensitivity analyses corroborated these findings. In summary, rare heterozygous variants in NEUROD1 and PDX1 are low-penetrance causes of MODY, while those in APPL1 and WFS1 lack robust genetic evidence for causality and should not be included in MODY testing panels. Article Highlights Testing genes with limited evidence of causality risks misdiagnosis of maturity-onset diabetes of the young (MODY). There is limited evidence as to whether rare variants in PDX1, NEUROD1, APPL1, and WFS1 cause MODY. Rare damaging variants in APPL1 and WFS1 are not enriched in a MODY cohort, but those in PDX1 and NEUROD1 are, at a level similar to low-penetrance MODY genes. PDX1 and NEUROD1 should be included in MODY gene panels, while heterozygous APPL1 and WFS1 variants should not be reported as causes of MODY.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trans-ActivatorsDiabetes Mellitus, Type 2Membrane ProteinsBasic Helix-Loop-Helix ProteinsHomeodomain ProteinsAdaptor Proteins, Signal TransducingHumansFemaleMalePenetranceGenetic Predisposition to DiseaseAdult

Substanzen

Trans-ActivatorsMembrane ProteinsBasic Helix-Loop-Helix ProteinsHomeodomain ProteinsAdaptor Proteins, Signal Transducingpancreatic and duodenal homeobox 1 proteinwolframin proteinNEUROD1 protein, human

Autor:innen und Institutionen

  • Department of Clinical and Biomedical Science, University of Exeter, Exeter, U.K.
  • Royal Devon and Exeter National Health Service Foundation Trust, Exeter, U.K.

ORCID-Profile: Andrew T Hattersley, Michael N Weedon, Kevin Colclough, Thomas W Laver, Kashyap A Patel

Förderung

  • Wellcome Trust
  • European Foundation for the Study of Diabetes

Zitieren

APA

Sriram, A., Wakeling, M. N., Hattersley, A. T., Weedon, M. N., Colclough, K., Laver, T. W., & Patel, K. A. (2025). Rare Variants in NEUROD1 and PDX1 Are Low-Penetrance Causes of MODY, Whereas Those in APPL1 and WFS1 Are Not Associated With MODY. Diabetes. https://doi.org/10.2337/db25-0442

Vancouver

Sriram A, Wakeling MN, Hattersley AT, Weedon MN, Colclough K, Laver TW, et al. Rare Variants in NEUROD1 and PDX1 Are Low-Penetrance Causes of MODY, Whereas Those in APPL1 and WFS1 Are Not Associated With MODY. Diabetes. 2025. doi:10.2337/db25-0442

BibTeX
@article{Sriram2025,
  author = {Sriram, Aparajita and Wakeling, Matthew N and Hattersley, Andrew T and Weedon, Michael N and Colclough, Kevin and Laver, Thomas W and Patel, Kashyap A},
  title = {Rare Variants in NEUROD1 and PDX1 Are Low-Penetrance Causes of MODY, Whereas Those in APPL1 and WFS1 Are Not Associated With MODY},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db25-0442}
}
Kostenlos starten →